1,517 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Tomum recalled its Minoxidil Hair Growth Treatment on March 5, 2026, due to serious poisoning risks to children. The product lacks required child-resistant packaging, increasing the risk of ingestion. Consumers should stop using the product immediately and contact the company for a safe replacement.
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Joly's LLC recalled 80% Vinegar on February 19, 2026, due to serious risks of poisoning and chemical burns. The product lacks essential warning labels and first aid instructions, violating federal safety laws. Consumers should stop using the product immediately and seek a refund.
Vive Health recalled adult portable bed rails on February 19, 2026, due to serious entrapment risks. The recall affects models LVA1024 and LVA3031BLK. Consumers must stop using the product immediately and contact Vive Health for a full refund.
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Stability Data Does Not Support Expiry Date.
Stability Data Does Not Support Expiry Date.
Stability Data Does Not Support Expiry Date.
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Defective container; inadequately sealed blister packaging.
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
AvKARE recalled Amantadine HCl capsules on February 13, 2026, due to failed dissolution specifications. The recall affects the 100 mg capsules, which may not dissolve properly. Consumers should stop using this product and contact their healthcare provider immediately.
Watkins Manufacturing recalled Hydromassage rotary jets from Highlife Collection spas on February 12, 2026. The jets pose entanglement and drowning hazards to users. Consumers should stop using the jets immediately and check their spas for the recalled parts.
Slate Run Pharmaceuticals recalled Eptifibatide Injection on February 12, 2026. The recall affects all lots of the 75 mg/100 mL vial due to incorrect dosing information. Healthcare providers and consumers must stop using the product immediately.
LEO Pharma Inc. recalled 11,407 units of Adbry injection on February 10, 2026. The recall stems from a lack of assurance of sterility due to particulate matter identified as wool fiber. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Hitachi Ltd. recalled one unit of its Proton Beam Therapy System on February 6, 2026 due to a software anomaly. The issue may result in positional discrepancies during patient treatment. The recall affects distribution in Texas and Washington D.C.
Hitachi recalled its Proton Beam Therapy System on February 6, 2026, due to a software anomaly that may result in positional discrepancies. The recall affects one unit distributed in Texas and Washington D.C. Healthcare providers and patients must stop using the device immediately.
GM Gumili recalled its Wintergreen Essential Oil on February 6, 2026, after it was found to lack child-resistant packaging. The essential oil contains methyl salicylate, which poses a risk of poisoning to young children if ingested. Consumers should stop using the product immediately and return it for a full refund.
Organic Zing Birch Essential Oil bottles were recalled on February 5, 2026, due to poison risks for children. The essential oil contains methyl salicylate, which requires child-resistant packaging. The recall affects an undisclosed number of bottles sold online by Linkers.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.